摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-7-(2-Chloro-benzyloxycarbonylamino)-3-{(S)-2-[(9H-fluoren-9-ylmethoxycarbonylamino)-methyl]-3-methyl-butyrylamino}-heptanoic acid benzyl ester | 888966-29-8

中文名称
——
中文别名
——
英文名称
(S)-7-(2-Chloro-benzyloxycarbonylamino)-3-{(S)-2-[(9H-fluoren-9-ylmethoxycarbonylamino)-methyl]-3-methyl-butyrylamino}-heptanoic acid benzyl ester
英文别名
——
(S)-7-(2-Chloro-benzyloxycarbonylamino)-3-{(S)-2-[(9H-fluoren-9-ylmethoxycarbonylamino)-methyl]-3-methyl-butyrylamino}-heptanoic acid benzyl ester化学式
CAS
888966-29-8
化学式
C43H48ClN3O7
mdl
——
分子量
754.323
InChiKey
QYHBUEVOGRDBJY-NBWQQBAWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.17
  • 重原子数:
    54.0
  • 可旋转键数:
    18.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    132.06
  • 氢给体数:
    3.0
  • 氢受体数:
    7.0

反应信息

  • 作为反应物:
    描述:
    (S)-7-(2-Chloro-benzyloxycarbonylamino)-3-{(S)-2-[(9H-fluoren-9-ylmethoxycarbonylamino)-methyl]-3-methyl-butyrylamino}-heptanoic acid benzyl ester 在 palladium on activated charcoal 氢气溶剂黄146 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 26.0h, 生成 H-(S)-β3hHis-(2R,3S)-β2,3hAla(αMe)-(2R,3S)-β2,3hAla(αMe)-(S)-β2hVal-(S)-β3hLys-(2R,3S)-β2,3hAla(αMe)-(2R,3S)-β2,3hAla(αMe)-(R)-β3hCys-OH
    参考文献:
    名称:
    β-肽二级结构通过 Zn2+ 络合强化和强化——在通往β-肽锌指的道路上?
    摘要:
    The correlation between beta(2)-, beta(3)-, and beta(2,3)-amino acid-residue configuration and stability of helix and hairpin-turn secondary structures of peptides consisting of homologated proteinogenic amino acids is analyzed (Figs. 1-3). To test the power of Zn2+ ions in fortifying and/or enforcing secondary structures of beta-peptides, a beta-decapeptide, 1, four beta-octapeptides, 2-5, and a P-hexadecapeptide, 10, have been devised and synthesized. The design was such that the peptides would a) fold to a 14-helix (I and 3) or a hairpin turn (2 and 4), or form neither of these two secondary structures (i.e., 5), and b) carry the side chains of cysteine and histidine in positions, which will allow Zn2+ ions to use their extraordinary affinity for RS- and the imidazole N-atoms for stabilizing or destabilizing the intrinsic secondary structures of the peptides. Tlie beta-hexadecapeptide 10 was designed to a) fold to a turn, to which a 14-helical structure is attached through a P-dipeptide spacer, and b) contain two cysteine and two histidine side chains for Zn complexation, in order to possibly mimic a Zn-finger motif While CD spectra (Figs6-8 and 17) and ESI mass spectra (Figs. 9 and 18) are compatible with the expected effects of Zn 21 ions in all cases, it was shown by detailed NMR analyses of three of the peptides, i.e., 2, 3,5, in the absence and presence of ZnCl2, that i) beta-peptide 2 forms a hairpin turn in H2O, even without Zn complexation to the terminal beta(3)hHis and 3 hCys side chains (Fig. 11), ii) beta-peptide 3, which is present as a 14-helix in MeOH, is forced to a hairpin-turn structure by Zn complexation in H2O (Fig. 12), and iii) beta-peptide 5 is poorly ordered in CD3OH (Fig. 13) and in H2O (Fig. 14), with far-remote beta(3)hCys and beta(3)hHis residues, and has a distorted turn structure in the presence of Zn 21 ions in H2O, with proximate terminal Cys and His side chains.
    DOI:
    10.1002/hlca.339
  • 作为产物:
    参考文献:
    名称:
    β-肽二级结构通过 Zn2+ 络合强化和强化——在通往β-肽锌指的道路上?
    摘要:
    The correlation between beta(2)-, beta(3)-, and beta(2,3)-amino acid-residue configuration and stability of helix and hairpin-turn secondary structures of peptides consisting of homologated proteinogenic amino acids is analyzed (Figs. 1-3). To test the power of Zn2+ ions in fortifying and/or enforcing secondary structures of beta-peptides, a beta-decapeptide, 1, four beta-octapeptides, 2-5, and a P-hexadecapeptide, 10, have been devised and synthesized. The design was such that the peptides would a) fold to a 14-helix (I and 3) or a hairpin turn (2 and 4), or form neither of these two secondary structures (i.e., 5), and b) carry the side chains of cysteine and histidine in positions, which will allow Zn2+ ions to use their extraordinary affinity for RS- and the imidazole N-atoms for stabilizing or destabilizing the intrinsic secondary structures of the peptides. Tlie beta-hexadecapeptide 10 was designed to a) fold to a turn, to which a 14-helical structure is attached through a P-dipeptide spacer, and b) contain two cysteine and two histidine side chains for Zn complexation, in order to possibly mimic a Zn-finger motif While CD spectra (Figs6-8 and 17) and ESI mass spectra (Figs. 9 and 18) are compatible with the expected effects of Zn 21 ions in all cases, it was shown by detailed NMR analyses of three of the peptides, i.e., 2, 3,5, in the absence and presence of ZnCl2, that i) beta-peptide 2 forms a hairpin turn in H2O, even without Zn complexation to the terminal beta(3)hHis and 3 hCys side chains (Fig. 11), ii) beta-peptide 3, which is present as a 14-helix in MeOH, is forced to a hairpin-turn structure by Zn complexation in H2O (Fig. 12), and iii) beta-peptide 5 is poorly ordered in CD3OH (Fig. 13) and in H2O (Fig. 14), with far-remote beta(3)hCys and beta(3)hHis residues, and has a distorted turn structure in the presence of Zn 21 ions in H2O, with proximate terminal Cys and His side chains.
    DOI:
    10.1002/hlca.339
点击查看最新优质反应信息

同类化合物

(S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 黎芦碱 鳥胺酸 魏因勒卜链接剂 雷迪帕韦二丙酮合物 雷迪帕韦中间体6 雷迪帕韦 雷迪帕维中间体 雷迪帕维中间体 雷尼托林 锰(2+)二{[乙酰基(9H-芴-2-基)氨基]氧烷负离子} 醋酸丁酸纤维素 达托霉素杂质 赖氨酸杂质4 试剂9,9-Dioctyl-9H-fluoren-2-amine 螺[环戊烷-1,9'-芴] 螺[环庚烷-1,9'-芴] 螺[环己烷-1,9'-芴] 螺[3.3]庚烷-2,6-二-(2',2'',7',7''-四碘螺芴) 螺-(金刚烷-2,9'-芴) 螺(环己烷-1,9'-芴)-3-酮 藜芦托素 荧蒽 反式-2,3-二氢二醇 草甘膦-FMOC 英地卡胺 苯芴醇杂质A 苯甲酸-(芴-9-基-苯基-甲基酯) 苯甲酸-(9-苯基-芴-9-基酯) 苯并[b]芴铯盐 苯并[a]芴酮 苯基芴胺 苯基(9-苯基-9-芴基)甲醇 苯(甲)醛,9H-芴-9-亚基腙 苯(甲)醛,4-羟基-3-甲氧基-,(3-甲基-9H-茚并[2,1-c]吡啶-9-亚基)腙 芴甲氧羰酰胺 芴甲氧羰酰基高苯丙氨酸 芴甲氧羰酰基肌氨酸 芴甲氧羰酰基环己基甘氨酸 芴甲氧羰酰基正亮氨酸 芴甲氧羰酰基D-环己基甘氨酸 芴甲氧羰酰基D-Β环己基丙氨酸 芴甲氧羰酰基-O-三苯甲基丝氨酸 芴甲氧羰酰基-D-正亮氨酸 芴甲氧羰酰基-6-氨基己酸 芴甲氧羰基-高丝氨酸内酯 芴甲氧羰基-缬氨酸-1-13C 芴甲氧羰基-叔丁基二甲基硅-D-丝氨酸 芴甲氧羰基-beta-赖氨酰酸(叔丁氧羰基) 芴甲氧羰基-S-叔丁基-L-半胱氨酸五氟苯基脂